High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
This piece breaks down the core influences on market indices, from macro indicators to liquidity, helping you anticipate possible moves.
27,686 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Imagine owning stocks that pay you reliably for decades. This guide shows how to find the best dividend stocks hold a...
The Federal Reserve flat-pedals its policy rate at 3.75% amid stubborn inflation, while guidance on a potentially lar...
Royal Caribbean enters 2026 with strong demand, but fuel cost headwinds and a heavy capex slate threaten margins, rem...
Duke University researchers unveiled Argus, a 20-legged robot capable of moving in any direction. The breakthrough co...
FinHarbor debuts Money Flow, a payment orchestration module for crypto and fiat that speeds deployment timelines and ...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Rackspace enters 2026 with a clearer path toward hybrid cloud leadership, but investors will scrutinize margins, cash...
When a headline pairs two combat icons, it’s more than hype—it’s a blueprint for money decisions. This piece turns th...
When a fintech stalwart like Fiserv experiences a pullback, it can ripple through the broader market. This guide expl...
A former hedge-fund executive warns that investors dangerously complacent about Iran conflict risks as oil volatility...